நகராட்சி நிறுவனம் ஆஃப் குண்டு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நகராட்சி நிறுவனம் ஆஃப் குண்டு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நகராட்சி நிறுவனம் ஆஃப் குண்டு Today - Breaking & Trending Today

Mumbai COVID-19 hospital moves SC, seeks action against supply agency for 'denying' oxygen on approved price

The plea further said that at a time when there is great shortage of beds and ICU facilities for the treatment of COVID patients, the petitioner hospital, one well equipped with all modern, hybrid facilities for COVID treatment, is forced to remain handicapped, practically closed. The plea sought directions to the Maharashtra government, Union of India and other instrumentalities of the state, and in particular, the Municipal Corporation of Bombay, the District Magistrate, Bombay Suburban District, the police authorities to take appropriate measures on a war-footing to ensure that sufficient quantity of oxygen is made available to the petitioner hospital as soon as possible, so that the lives of the COVID patients could be saved. It further sought directions to the governments and authorities to take appropriate action against Indo Gas Agency, including criminal proceedings, for violation of the Essential Commodities Act, 1955, for selling oxygen cylinders in the black market ....

Bombay Suburban District , Indo Gas Agency , Union Of India , Municipal Corporation Of Bombay , Municipal Corporation , District Magistrate , Essential Commodities Act , Supreme Court , Covid 19 Hospital , குண்டு புறநகர் மாவட்டம் , தொழிற்சங்கம் ஆஃப் இந்தியா , நகராட்சி நிறுவனம் ஆஃப் குண்டு , நகராட்சி நிறுவனம் , மாவட்டம் மாஜிஸ்திரேட் , அவசியம் பொருட்கள் நாடகம் , உச்ச நீதிமன்றம் ,

Covid-19 | Hospital moves Supreme Court against oxygen supplier

Claims anti-social, inhuman elements are creating artificial shortage to enrich themselves ....

Bombay Suburban District , Manju Jetley Sharma , Supreme Court , Life Hospital Ltd , Municipal Corporation Of Bombay , Union Of India , Crystal Hospital Ltd , Hospital Ltd , Municipal Corporation , District Magistrate , Essential Commodities Act , Nihs Re Life Hospital Ltd , Private Individuals , Corona Virus , Covid 19 , Second Wave , குண்டு புறநகர் மாவட்டம் , உச்ச நீதிமன்றம் , நகராட்சி நிறுவனம் ஆஃப் குண்டு , தொழிற்சங்கம் ஆஃப் இந்தியா , மருத்துவமனை லிமிடெட் , நகராட்சி நிறுவனம் , மாவட்டம் மாஜிஸ்திரேட் , அவசியம் பொருட்கள் நாடகம் , ப்ரைவேட் தனிநபர்கள் , கொரோனா வைரஸ் ,

Mumbai COVID hospital moves SC, seeks action against supply agency for 'denying' oxygen on approved price

Representative Image
ANI |
Updated: May 11, 2021 22:30 IST
New Delhi [India], May 11 (ANI): A Mumbai based COVID-19 hospital approached the Supreme Court on Tuesday alleging that an oxygen supplier Indo Gas has denied the supply of medical oxygen to the hospital forcing patients to be transferred to other hospitals.
The plea was filed by Crystal Hospital Ltd, now renamed as NIHS Re-Life Hospital Ltd, Mumbai, which said that the hospital was willing to pay five times the approved price, but Indo Gas denied supply and demanded a minimum of 10 times the official rate.
The petition said the NIHS Re-Life Hospital is a COVID hospital with 90 beds of which 13 have hi-tech ICU facilities. ....

Bombay Suburban District , New Delhi , Life Hospital Ltd , Indo Gas Agency , Municipal Corporation Of Bombay , Union Of India , Supreme Court On , Crystal Hospital Ltd , Supreme Court , Indo Gas Has , Indo Gas , Life Hospital , Municipal Corporation , District Magistrate , Essential Commodities Act , குண்டு புறநகர் மாவட்டம் , புதியது டெல்ஹி , நகராட்சி நிறுவனம் ஆஃப் குண்டு , தொழிற்சங்கம் ஆஃப் இந்தியா , உச்ச நீதிமன்றம் ஆன் , உச்ச நீதிமன்றம் , வாழ்க்கை மருத்துவமனை , நகராட்சி நிறுவனம் , மாவட்டம் மாஜிஸ்திரேட் , அவசியம் பொருட்கள் நாடகம் ,

India's drug regulator has failed the pandemic stress test

By Dinesh Thakur Dec. 11, 2020Reprints
The approval of itolizumab, a drug made by Biocon, for treating Covid-19 in India has come under fire.
Aijaz Rahi/AP
The Covid-19 pandemic has served as a stress test for drug regulators across the world. India’s has failed.
Amid the desperate scrambles for therapeutics and vaccines to stem the havoc caused by the pandemic, drug regulators have had to resist tremendous political pressure to approve unproven therapies. Rick Bright, the former head of the Biomedical Advanced Research and Development Authority (BARDA), the federal agency that helps secure the U.S. from chemical, biological, radiological, nuclear, and emerging infectious disease threats, left his position, alleging in his whistleblower complaint that he faced political pressure to allow the distribution of hydroxychloroquine, an unproven drug for treating Covid-19 that had been championed by President Trump. ....

United States , Itolizumab Alzumab , Sundar Ramanan , Oxford Astrazeneca , Biomedical Advanced Research , World Health Organization , Municipal Corporation Of Bombay , Glenmark Pharmaceuticals , Development Authority , Central Drugs Standard Control Organization , United States Agency For International Development , Japan Fujifilm Group , Serum Institute Of India , National Taskforce Of The Government India , World Health , United States Agency , International Development , Drug Controller General , National Task Force , Cosmetics Act , Federal Register , Information Act , New Drugs , Clinical Trial Rules , Fujifilm Group , Mumbai Based Glenmark ,